Neutralization potential of the plasma of HIV-1 infected Indian patients in the context of anti-V3 antibody content and antiretroviral theraphy

Journal of Microbiology

Volumn 50, Issue 1, 2012, Pages 149-154

  Choudhary, Alok Kumar ^a   Andrabi, Raiees ^a   Prakash, Somi Sankaran ^a   Kumar, Rajesh ^a   Choudhury, Shubhasree Dutta ^a   Wig, Naveet ^a   Biswas, Ashutosh ^a   Hazarika, Anjali ^a   Luthra, Kalpana ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

anti V3 antibodies; antiretroviral therapy; HIV 1; India; neutralizing antibodies

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY;

ADULT; ARTICLE; BLOOD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; INDIA; MALE; MIDDLE AGED; PLASMA; SERODIAGNOSIS; VIROLOGY;

ADULT; ANTI-HIV AGENTS; ANTIBODIES, NEUTRALIZING; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; INDIA; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; PLASMA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863395514     PISSN: 12258873     EISSN: 19763794     Source Type: Journal    
DOI: 10.1007/s12275-012-1246-y     Document Type: Article

References (19)

1. Dreyer, K., Kallas, E. G., Planelles, V., Montefiori, D., McDermott, M. P., Hasan, M. S., and Evans, T. G. 1999. Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses15, 1563-1571.
2. Fouts, T. R., Binley, J. M., Trkola, A., Robinson, J. E., and Moore, J. P. 1997. Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex. J. Virol. 71, 2779-2785.
3. Frost, S. D., Wrin, T., Smith, D. M., Kosakovsky Pond, S. L., Liu, Y., Paxinos, E., Chappey, C., Galovich, J., Beauchaine, J., Petropoulos, C. J., andet al. 2005. Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc. Natl. Acad. Sci. USA102, 18514-18519.
4. Huang, C. C., Tang, M., Zhang, M. Y., Majeed, S., Montabana, E., Stanfield, R. L., Dimitrov, D. S., Korber, B., Sodroski, J., Wilson, I. A., andet al. 2005. Structure of a V3-containing HIV-1 gp120 core. Science310, 1025-1028.
5. Kim, J. H., Mascola, J. R., Ratto-Kim, S., VanCott, T. C., Loomis-Price, L., Cox, J. H., Michael, N. L., Jagodzinski, L., Hawkes, C., Mayers, D., andet al. 2001. Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infection. AIDS Res. Hum. Retroviruses17, 1021-1034.
6. Kulkarni, S., Tripathy, S., Gangakhedkar, R., Jadhav, S., Agnihotri, K., Sane, S., Bollinger, R., and Paranjape, R. 2008. Neutralizing antibody responses in recent seroconverters with HIV-1 subtype C infections in India. AIDS Res. Hum. Retroviruses24, 1159-1166.
7. Lakhashe, S. K., Kulkarni, S. S., Thakar, M. R., Ghate, M. V., and Paranjape, R. S. 2007. Extensive cross-reactive neutralizing antibody response in Indian patients with limited genetic diversity of HIV-1. Virology359, 295-301.
8. Li, M., Gao, F., Mascola, J. R., Stamatatos, L., Polonis, V. R., Koutsoukos, M., Voss, G., Goepfert, P., Gilbert, P., Greene, K. M., andet al. 2005. Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies. J. Virol. 79, 10108-10125.
9. Morris, L., Binley, J. M., Clas, B. A., Bonhoeffer, S., Astill, T. P., Kost, R., Hurley, A., Cao, Y., Markowitz, M., Ho, D. D., andet al. 1998. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J. Exp. Med. 188, 233-245.
10. Nandi, A., Lavine, C. L., Wang, P., Lipchina, I., Goepfert, P. A., Shaw, G. M., Tomaras, G. D., Montefiori, D. C., Haynes, B. F., Easterbrook, P., andet al. 2010. Epitopes for broad and potent neutralizing antibody responses during chronic infection with human immunodeficiency virus type 1. Virology396, 339-348.
11. Ozkaya Sahin, G., Bowles, E. J., Parker, J., Uchtenhagen, H., Sheik-Khalil, E., Taylor, S., Pybus, O. G., Makitalo, B., Walther-Jallow, L., Spangberg, M., andet al. 2010. Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. PLoS Pathog. 6, e1001084.
12. Parren, P. W., Burton, D. R., and Sattentau, Q. J. 1997. HIV-1 antibody-debris or virion? Nat. Med. 3, 366-367.
13. Richman, D. D., Wrin, T., Little, S. J., and Petropoulos, C. J. 2003. Rapid evolution of the neutralizing antibody response to HIV type 1 infection. Proc. Natl. Acad. Sci. USA100, 4144-4149.
14. Sarmati, L., Nicastri, E., el-Sawaf, G., Ventura, L., Salanitro, A., Ercoli, L., Vella, S., and Andreoni, M. 1997. Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (Invirase) treatment. J. Med. Virol. 53, 313-318.
15. Schuitemaker, H. and Kootstra, N. A. 2005. Isolation, propagation, and titration of human immunodeficiency virus type 1 from peripheral blood of infected individuals. Methods Mol. Biol. 304, 17-24.
16. Spenlehauer, C., Saragosti, S., Fleury, H. J., Kirn, A., Aubertin, A. M., and Moog, C. 1998. Study of the V3 loop as a target epitope for antibodies involved in the neutralization of primary isolates versus T-cell-line-adapted strains of human immunodeficiency virus type 1. J. Virol. 72, 9855-9864.
17. Stanfield, R. L., Gorny, M. K., Zolla-Pazner, S., and Wilson, I. A. 2006. Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. J. Virol. 80, 6093-6105.
18. Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., andet al. 2003. Antibody neutralization and escape by HIV-1. Nature422, 307-312.
19. Zolla-Pazner, S., Cohen, S. S., Krachmarov, C., Wang, S., Pinter, A., and Lu, S. 2008. Focusing the immune response on the V3 loop, a neutralizing epitope of the HIV-1 gp120 envelope. Virology372, 233-246.